Sodium 1,4-dioxo-1,4-bis(tridecyloxy)butane-2-sulfonate, 65%, 100g

2,3-Dimethylanthraquinone>95.0%(GC)1g

(S)-2-(2,6,7,8-TETRAHYDRO-1H-INDENO[5,4-B]FURAN-8-YL)ETHANAMINE HCL, 97%, 500mg

4-Bromo-2-cyclopropoxypyridine, 95.0%, 1g

Methyl 5-((4-bromo-2-fluorophenyl)amino)-4-fluoro-1H-benzo[d]imidazole-6-carboxylate, 98%, 250mg

4-Bromo-p-terphenyl, 95.0%, 5g

Ethyl 4-amino-6-chloro-5-fluoronicotinate, 97%, 1g

3,3'-DIMETHYLAZOBENZENE, 98%, 1g

3,3-Dimethoxycyclobutanecarboxylic acid, 95.0%, 10g

(R)-1-(3-(Trifluoromethoxy)phenyl)ethanamine hydrochloride, 95.0%, 100mg

Ethyl 4-(3-methoxyphenyl)thiazole-2-carboxylate, 95.0%, 5g

4-(2-chlorophenyl)-3-methyl-1H-pyrazol-5-amine, 95.0%, 1g

Matraz receptor con revestimiento de PUR, 1000 ml, 1 pieza